Vietnam Investment Review on MSN
HanchorBio Secures US Patent for Innovative SIRPα CD47 Fusion Protein HCB101
TAIPEI and SHANGHAI and SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ -- HanchorBio today announced that its proprietary HCB101, a SIRPα/CD47 fusion protein candidate, has been officially granted a US ...
今年,细胞出版社中国科学家与 Cell Press 活动迎来了第十年。在过去的 2024 年里,中国科研工作者在 Cell Press 旗下的生命科学、医学、物质科学、交叉科学、可持续发展等领域的期刊发表的原创研究型论文超过 2400 ...
This valuable study addresses the effects of selection on aggression on fitness and life-history trade-offs in Drosophila melanogaster. However, the evidence presented is incomplete and does not ...
ScienceAlert on MSN
Parkinson's Discovery Suggests We May Have an FDA-Approved Treatment Already
Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material ...
今日与大家汇报原发性纤毛运动障碍(PCD)的进展,我认为对我们未来的工作有所帮助和启发。一、PCD的定义及诊断流程首先看PCD的定义,它强调以支气管扩张为主的呼吸道表现。它是因为先天性的纤毛结构或功能异常,或者多运动纤毛生成减少,导致的呼吸道黏液清除 ...
Design We performed single-cell RNA sequencing on 24 patients with GC and spatial transcriptomic profiling on formalin-fixed paraffin-embedded tissue sections from patients and controls. Integrating ...
Cluster 4/5 was treated with the dual ICI regimen of ipilimumab plus nivolumab. This arm remains open to accrual. Clusters 3, 6, and 7 were excluded from the study. Additional secondary endpoints are ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果